Takeda Pharmaceutical Company Limited (TYO:4502)
5,480.00
+135.00 (2.53%)
Jul 17, 2026, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or -0.90% compared to the previous year.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
95.81M JPY
Profits / Employee
-3.24M JPY
Market Cap
8.66T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eisai | 10,543 |
| Shionogi & | 6,223 |
| Sumitomo Pharma | 4,980 |
| Tsumura & Co. | 4,923 |
| Towa Pharmaceutical | 4,923 |
| Sawai Group Holdings | 3,630 |
| Nippon Shinyaku | 2,309 |
| Kissei Pharmaceutical | 1,786 |
Takeda Pharmaceutical Company News
- 15 hours ago - Takeda's QDENGA becomes first dengue vaccine approved in India - Reuters
- 3 days ago - Takeda's Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies - Business Wire
- 7 days ago - Takeda Pharmaceutical (TAK) Launches Plasma Ecosystem Initiative in Indonesia - GuruFocus
- 7 days ago - Takeda, the Indoensian Government announce collaboration - TheFly
- 7 days ago - Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products - Business Wire
- 17 days ago - Takeda Pharmaceutical Co Ltd (TAK) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
- 18 days ago - Insilico Medicine Announces Strategic AI Drug Discovery Collaboration With Takeda - Nasdaq
- 18 days ago - Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery - PRNewsWire